Poliomyelitis prevention in the United States: New recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine

Pediatric Annals

Volumn 26, Issue 6, 1997, Pages 378-383

  Prevots, D Rebecca ^a   Strebel, Peter M ^a  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

HUMAN; INFECTION PREVENTION; POLIOMYELITIS; REVIEW; UNITED STATES; VACCINATION;

EID: 0031470182     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19970601-09     Document Type: Review

References (13)

1. Centers for Disease Control and Prevention (CDC). Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46(RR-3):1-25.
2. American Academy of Pediatrics (COID). Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. Pediatrics. 1997;99:300-305.
3. Centers for Disease Control and Prevention (CDC). Recommended childhood immunization schedule - United States, 1997. MMWR. 1997;46:35-40.
4. Prevots DR, Sutter RW, Strebel PM, et al. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Arch Pediatr Adolesc Med. 1994;148:479-485.
5. Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14:568-579.
6. Centers for Disease Control and Prevention (CDC). Paralytic poliomyelitis - United States, 1980-1994. MMWR. 1997;46:79-83.
7. Centers for Disease Control and Prevention (CDC). Certification of poliomyelitis elimination - the Americas, 1994-MMWR. 1994;43:720-722.
8. Ministry of Health, Ontario. Wild type poliovirus isolated in Hamilton. Public Health and Epidemiology Report, Ontario. 1996;7:51-52.
9. Modlin FJ, Halsey NA, Thorns MO, Meschievitz, CK, Pattiarca, and the Baltimore Area Polio Vaccine Study Group. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-five attenuated oral puliovirus vaccine immunization schedules. J Infect Dis. 1997;175(suppl 1):S228-234.
10. Miller MA, Sutter RW, Strebel PM, Hadler SC. Cost-effectiveness of incorpotating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA. 1996;276:967-971.
11. Cohen-Abbo A, Culley BS, Reed GW, et al. Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval. Pediatr Infect Dis J. 1995;14:100-106.
12. Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1994; 43(RR-1):1-33.
13. American Academy of Pediatrics. In: Peter G, ed. 1994 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1997;681-688.